Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed May 8, 2014 · 10-Q · 38 days after period end · 0001193125-14-188608
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Net Income | -$28.27M | -$42.08M | -$17.70M | $1.83M |
| EPS Diluted | -$0.75 | -$1.32 | -$0.78 | $0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 8, 2014 · 38 d after period end
